Why Peptide Solutions Go Cloudy: Aggregation and Handling
Shaking a reconstituted peptide is the most common way to ruin one. The interfacial mechanism behind aggregation, why lipidated peptides are worse, and the handling practice that follows from it.
The most common way to ruin a research peptide is not storage temperature, not light exposure, and not time. It is shaking the vial after adding diluent.
Understanding why makes the handling advice something other than ritual.
What aggregation is
Aggregation is peptide molecules associating with one another instead of remaining as individual molecules in solution. Depending on scale it presents as invisible soluble oligomers, faint haze, visible cloudiness, or discrete particles.
The consequence is straightforward and unwelcome: aggregated peptide is not equivalent to monomeric peptide. It is not available to bind a receptor, it behaves differently in every assay that depends on molecular interaction, and the effective concentration of usable material is now lower than the arithmetic says — by an unknown amount.
It is also, for practical purposes, irreversible. Once formed, aggregates do not spontaneously return to monomer under ordinary conditions.
The interfacial mechanism
Aggregation begins at surfaces, and the most damaging surface in a vial is the one between liquid and air.
Peptides are amphipathic to some degree: they carry both hydrophilic and hydrophobic regions. In bulk solution, the hydrophobic regions are shielded — folded inward, or solvated as well as water manages.
An air-liquid interface offers a better arrangement. The peptide adsorbs, with hydrophobic regions oriented into the air and hydrophilic regions into the water. That reorientation requires partial unfolding, and it produces two conditions that together initiate aggregation:
- Unfolded molecules with hydrophobic regions exposed.
- High local concentration, because they are all crowded into a two-dimensional film.
Exposed hydrophobic surfaces adjacent to one another associate. That is the nucleus. Once a nucleus exists it grows by recruiting further molecules, and the process accelerates.
Shaking creates enormous amounts of interface. Every bubble is surface area, and it is being continuously created and destroyed — repeatedly presenting fresh interface, adsorbing peptide, then collapsing and delivering the partially unfolded product back into the bulk solution to nucleate further aggregation.
A swirl mixes. A shake manufactures the exact conditions aggregation needs.
Why lipidated peptides are worse
Several compounds in metabolic research carry a fatty acid chain — retatrutide, tirzepatide and semaglutide all use a fatty-diacid conjugate to bind albumin and extend half-life.
That chain does in a vial what it does in plasma: it seeks a hydrophobic environment. In the absence of albumin, the available hydrophobic environments are the air-liquid interface, the vial wall, and other peptide molecules.
Lipidated peptides therefore accumulate at interfaces faster and at lower concentrations than unmodified peptides of similar size. They are also prone to forming ordered self-assembled structures rather than simple amorphous clumps, which can produce a solution that looks acceptable while containing very little monomer.
For these compounds the handling advice is not general good practice — it is a requirement.
Other contributing factors
Concentration. Aggregation is concentration-dependent, and often disproportionately so. Reconstituting to a very high concentration for convenience raises the risk considerably.
Temperature cycling. Each freeze-thaw concentrates the peptide in the shrinking unfrozen fraction as ice forms, then creates new ice-liquid interface on thawing. Both promote aggregation. Aliquot once and freeze the aliquots rather than repeatedly thawing one vial.
pH. Peptides are least soluble near their isoelectric point, where net charge is zero and there is no electrostatic repulsion between molecules. A diluent whose pH sits near a given peptide's pI is asking for trouble.
Surfaces generally. Glass and plastic both adsorb peptide. For a dilute solution of an adsorption-prone peptide this can remove a meaningful fraction of the material — a concentration error rather than aggregation as such, but a real one, and the reason low-binding plasticware exists.
Trace metals. Copper and iron catalyse oxidation of methionine, cysteine and tryptophan, and oxidised peptide aggregates more readily than the parent. Clean diluent matters more than it seems.
The handling that follows
Reconstitution
Bring the vial to room temperature first — 20–30 minutes from −20 °C. Opening a cold vial condenses atmospheric moisture onto the cake, and adding diluent to cold material slows dissolution, extending the time material spends partly-dissolved.
Run the diluent down the inside wall. Not onto the cake directly. This wets the material gradually rather than driving a jet into it, and it minimises splashing — which is interface.
Swirl gently, or leave it. Most well-lyophilised peptides dissolve without any agitation at all in a minute or two. If it needs help, swirl slowly. Do not invert repeatedly, do not vortex, do not shake.
Do not pipette vigorously up and down. Same problem, smaller scale.
Be patient. A collapsed cake dissolves slowly because it has lost the porous surface area a good cake has. Slow dissolution is a reason to wait, not a reason to shake. See reading the cake.
Storage in solution
- 2–8 °C, protected from light, for short-term use.
- Aliquot before freezing where longer storage is needed, so each aliquot is thawed once.
- Label with concentration and date. Nothing about a clear solution tells you either, and the vial no longer looks different from any other clear solution in the fridge.
- Inspect before use — hold it to the light. Haze, floaters or a visible meniscus film mean aggregation has already happened.
If it has gone cloudy
Realistically, the material is compromised.
Filtering through 0.22 μm removes the visible particles, but it also removes the peptide that formed them — leaving a clear solution at an unknown, lower concentration. That is worse than an obviously cloudy one, because it looks usable.
Warming and sonication are sometimes suggested. Both add energy to a system whose problem is that molecules have already found a lower-energy associated state, and sonication in particular generates cavitation, which generates interface.
The realistic options are to discard it, or — if the material is expensive and the work tolerant — to characterise what remains rather than assume the arithmetic still holds.
The short version
Aggregation starts at the air-liquid interface. Shaking manufactures that interface. Swirl, run diluent down the wall, keep concentrations reasonable, aliquot before freezing, and treat lipidated peptides as the fragile end of the range.
Related: the reconstitution calculator for the arithmetic, and water content and lyophilisation quality for what the cake tells you before you add anything to it.